Atea Pharmaceuticals Inc (AVIR)
3.31
+0.06
(+1.85%)
USD |
NASDAQ |
Nov 22, 10:20
Atea Pharmaceuticals Total Liabilities (Quarterly): 32.44M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 32.44M |
| June 30, 2024 | 33.91M |
| March 31, 2024 | 48.66M |
| December 31, 2023 | 39.78M |
| September 30, 2023 | 26.34M |
| June 30, 2023 | 23.68M |
| March 31, 2023 | 19.95M |
| December 31, 2022 | 26.14M |
| September 30, 2022 | 23.39M |
| June 30, 2022 | 33.88M |
| Date | Value |
|---|---|
| March 31, 2022 | 37.30M |
| December 31, 2021 | 62.82M |
| September 30, 2021 | 262.05M |
| June 30, 2021 | 273.68M |
| March 31, 2021 | 254.39M |
| December 31, 2020 | 315.83M |
| September 30, 2020 | 186.62M |
| June 30, 2020 | 7.127M |
| December 31, 2019 | 71.64M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
7.127M
Minimum
Jun 2020
315.83M
Maximum
Dec 2020
93.66M
Average
37.30M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| McKesson Corp | 75.07B |
| Pfizer Inc | 126.92B |
| Doximity Inc | 157.32M |
| Immuneering Corp | 10.84M |
| CEL-SCI Corp | 15.60M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 490.96M |
| Shareholders Equity (Quarterly) | 458.52M |